Facts
as of Nov 17, 2026
Simplifying healthcare and benefits for you and your family. Caring for you rself and your family shouldn't be complicated or frustrating. It should be simple and reassuring.
It is hiring: 1 open role, 1 of them posted in the last 30 days.
- Legal name
- Accolade, Inc.
- Headquarters
- Plymouth Meeting, United States
- Employees
- 1,810US Form 5500 (plan participants) · Dec 2024
- Legal entities
- 2 in 1 countries
- Open roles
- 1Alion job postings
- Register numbers
- NAME accolade inc
- Website
- accolade.com
As of Nov 17, 2026, Alion lists 1 open role at Accolade. Accolade is headquartered in Plymouth Meeting, United States. It has raised $568.7M in 6 funding rounds. The latest round is Venture - Series Unknown of $11.3M, announced in 2021.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Accolade, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring at full speed: most open roles are fresh.
Finance is the largest family, 100 of open roles.
1Posted in 30 days100% of open roles are fresh
0%Remote roles0 of 1
1Hiring offices
Can they hire you from United States?by your location
Hires from your country
A regulated sector (Health Care): foreign contractors are rarely given access
Czech Republic1On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Where the openings areshare of open roles · trend
What postings ask forlanguages named in open roles
Benefits named in postingsshare of open roles
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Named in the work visa registers of United States.
1 ▼ 88%H-1B filings in 12 months
1Green card filings
$115kMedian offered salary
In the register as ACCOLADE, INC., Plymouth Meeting, PA (+1 more)
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Apr 6, 2026
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
PragueBusiest site
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$568.7MTotal raised
Venture - Series UnknownLatest round
6Rounds and grants
Money by yearUSD, rounds and grants
2021$466.5M3 records
2019$20M1 record
2018$27.2M1 record
2016$55M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers
Tech stack
Technologies named in job postings at Accolade over the last 12 months, by layer, with the share of postings for each.
1Technologies in use
1Postings analysed
85/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
top 0.06%Web presenceof 133.2M domains by links, Common Crawl
4.8 ★App Store46k ratings
Apr 8, 20252025
News · NBC New York
Transcarent CEO Glen Tullman previously led Livongo, which was purchased by Teladoc in a 2020 agreement that valued the company at$18.5 billion.
Feb 26, 20252025
News · TechCrunch
ProximaFusion, a two-year-old German nuclear fusion startup, has published plans for a working fusion power plant in a peer-reviewed journal, in what is
Jan 9, 20252025
News · MedCity News
Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to…
Jan 8, 20252025
News · STAT
Transcarent on Wednesday said it was buying Accolade, a health benefits company, for $621 million, offering a significant premium on Accolade's share price.
Jan 8, 20252025
News · hitconsultant.net
Transcarent will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash totalling $621M.
Sources: the outlets named on each headline, each story once